Home » Topics » BioWorld Science

BioWorld Science
RSS

Dana-Farber Cancer Institute, Voronoi patent wild-type and mutant LRRK2 inhibitors

May 12, 2020

New histone-lysine N-methyltransferase SMYD3 inhibitors identified at Epizyme

May 12, 2020

Array BioPharma discloses new PTPN11 inhibitors

May 12, 2020

CPU-025 demonstrates promising efficacy in mouse model of diabetes

May 12, 2020

PK and PD data presented for OPL-002 in healthy volunteers

May 12, 2020

Novel peptide-targeted approach improves potency of anticancer drugs

May 12, 2020

NIH initiates ACTT 2 study of remdesivir plus baricitinib in patients with COVID-19

May 12, 2020

TLR5 is a therapeutic target for treating chronic colonic hypersensibility

May 12, 2020

T-cell mutations contribute to GvHD

May 12, 2020

Prying mantis identifies disease genes

May 12, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...